Product image of Omeprazolo Git (Omeprazole) supplied by GNH India

Omeprazolo Git

Active Ingredient:
Omeprazole
Origin:
EU

Omeprazolo Git (Omeprazole)

Omeprazole, the active ingredient in Omeprazolo Git, is a proton pump inhibitor presented as a 20 mg tablet for oral use. It reduces stomach acid production and is used to treat acid‑related disorders in adults and children.
GNH India supplies Omeprazolo Git as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

S.F. Group Srl

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Omeprazole acts on the gastric acid secretion pathway and is indicated for several acid‑related conditions.

  • Gastro‑esophageal reflux disease (GERD): provides symptomatic relief and promotes healing of the esophageal lining.
  • Peptic ulcer disease: supports ulcer healing and reduces risk of recurrence.
  • Zollinger‑Ellison syndrome: controls excessive gastric acid production associated with the condition.

How It Works

  • Omeprazole selectively inhibits the H+/K+‑ATPase enzyme (the gastric proton pump) located on the secretory surface of parietal cells. By binding covalently to the pump’s cysteine residues, it blocks the final step of acid secretion, leading to a sustained increase in gastric pH and reduced acidity in the stomach.

Side Effects

Adverse reactions to omeprazole are generally mild to moderate and vary with duration of therapy.

Common Side Effects

  • Headache: mild, transient headache reported by some patients.
  • Diarrhea: loose stools occurring during early treatment.
  • Nausea: occasional feeling of queasiness.
  • Abdominal pain: mild discomfort in the stomach area.
  • Flatulence: increased intestinal gas.
  • Constipation: reduced bowel movements.

Serious or Rare Side Effects

  • Clostridioides difficile infection: severe colitis linked to altered gut flora.
  • Acute interstitial nephritis: sudden kidney inflammation.
  • Stevens‑Johnson syndrome: rare severe skin reaction.
  • Hepatotoxicity: elevated liver enzymes indicating liver stress.
  • Hypomagnesemia: low magnesium levels with prolonged use.
  • Fracture risk: increased incidence of hip, wrist or spine fractures with long‑term therapy.

Precautions & Warnings

When prescribing omeprazole, clinicians should consider several safety aspects.

  • Assess renal function: adjust use in patients with severe kidney impairment.
  • Review concomitant medications: evaluate for potential drug‑drug interactions.
  • Monitor long‑term use: consider periodic assessment of magnesium and bone health.
  • Pregnancy and lactation: use only if clearly needed after risk‑benefit evaluation.
  • Elderly patients: start with the lowest effective dose and monitor response.
  • Store below 25°C: keep in the original container, protect from moisture and direct sunlight.

Avoid Interactions

Omeprazole can affect the pharmacokinetics of several co‑administered drugs.

Major Interactions (Avoid)

  • Clopidogrel: reduced antiplatelet effect, increasing cardiovascular risk.
  • Atorvastatin: increased plasma concentration, raising risk of myopathy.
  • Methotrexate: higher systemic exposure, potentially causing toxicity.

Moderate Interactions (Monitor Closely)

  • Warfarin: possible alteration of INR, requiring more frequent monitoring.
  • Digoxin: modest increase in serum levels, may need dose adjustment.
  • Diazepam: enhanced sedation, monitor for excessive CNS depression.

Frequently Asked Questions

Omeprazolo Git contains omeprazole, which is prescribed to manage acid‑related disorders such as gastro‑oesophageal reflux disease, peptic ulcer disease and Zollinger‑Ellison syndrome. It works by lowering stomach acidity, helping to relieve symptoms and promote healing of the gastrointestinal lining.

Omeprazole belongs to the proton pump inhibitor class. It binds covalently to the H+/K+‑ATPase enzyme on gastric parietal cells, blocking the final step of acid secretion. This inhibition raises gastric pH, reducing the amount of acid that reaches the stomach and duodenum.

The specific dose of Omeprazolo Git is determined by the prescribing clinician based on the patient’s condition, severity and response to therapy. Dosage regimens are individualized and should follow the prescriber’s instructions and local labeling requirements.

Omeprazole is classified as pregnancy category B in many regions, indicating no evidence of fetal risk in animal studies, but limited human data. It should be used during pregnancy or lactation only when clearly needed, after a careful risk‑benefit assessment by the healthcare professional.

To place an order, submit an enquiry on the Omeprazolo Git product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Omeprazole, the active ingredient in Omeprazolo Git, is a proton pump inhibitor that provides more potent and longer‑lasting acid suppression than H2‑receptor antagonists such as ranitidine. Compared with newer PPIs, it has a well‑established efficacy and safety profile, though individual response and drug‑interaction potential may differ.

Omeprazolo Git tablets should be stored at temperatures not exceeding 25 °C, in the original packaging to protect from moisture and light. Keeping the product in a dry, cool environment helps maintain its potency throughout its shelf life.

Omeprazolo Git is supplied as oral tablets that are swallowed whole with a glass of water, typically before a meal. The tablet should not be crushed, chewed or split unless specifically instructed by a healthcare professional.

Serious, though rare, adverse events linked to omeprazole include Clostridioides difficile‑associated colitis, acute interstitial nephritis, severe skin reactions such as Stevens‑Johnson syndrome, and low magnesium levels with prolonged use. Patients should be monitored for these conditions, especially during long‑term therapy.

Individuals with known hypersensitivity to omeprazole or any component of the tablet formulation should not use Omeprazolo Git. Caution is also advised for patients taking clopidogrel, those with severe liver impairment, and patients requiring high‑dose vitamin B12 supplementation, as absorption may be reduced.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Omeprazole

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT